<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03048292</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 16-1290</org_study_id>
    <nct_id>NCT03048292</nct_id>
  </id_info>
  <brief_title>New York City Mobile Interventional Stroke Team</brief_title>
  <acronym>NYC MIST</acronym>
  <official_title>Reducing Disparities in Mechanical Embolectomy Access for Patients of New York City Via a Mobile Interventional Stroke Team: Systems of Care and Time-To-Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endovascular treatment has recently become the recommended therapy for acute stroke after the
      publication of five randomized trials (MR CLEAN1, ESCAPE2, EXTEND IA3, SWIFT PRIME4,
      REVASCAT5) in 2015 that demonstrate its efficacy. Hospitals need to adapt to these updated
      stroke care guidelines, and many hospitals are not appropriately equipped for
      neurointerventional procedures. Decreased time to treatment is associated with favorable
      clinical outcomes, and best practices to optimize workflow between comprehensive stroke
      centers and secondary hospitals have become an important area of study. This prospective
      study is being conducted on acute stroke cases within the Mount Sinai Health System from 1
      June 2016 up until 31 December 2018. The researchers would like to evaluate how variable
      methods of interventional service delivery for acute stroke affect clinical measures and
      outcomes.

      More specifically, the researchers are conducting this study in order to determine whether
      outcomes of neurointervention for large vessel occlusion in stroke, for patients presenting
      to and receiving treatment at a comprehensive stroke center, will be superior to that
      delivered by a mobilized intervention team at a central satellite hospital. In particular,
      the hypothesis is that factors affecting outcome include presentation to secondary hospital,
      delays with transfer including traffic conditions and time of day, and the acquisition of
      complex imaging within secondary hospitals.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment times</measure>
    <time_frame>90 days</time_frame>
    <description>Time between first hospital arrival and final recanalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to groin puncture procedure</measure>
    <time_frame>3 months</time_frame>
    <description>Time of first hospital arrival to groin puncture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of EMS contact to groin puncture</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS</measure>
    <time_frame>90 days</time_frame>
    <description>National Institutes of Health Stroke Scale (NIHSS) a 11-item impairment scale to evaluate neurologic outcome and degree of recovery.
Each item is scored between 0 and up to 4, (0 normal function with higher score indicating higher level of impairment. with minimum score 0 and maximum possible score 42.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Scale (mRS)</measure>
    <time_frame>90 days</time_frame>
    <description>the mRS measures degree of disability/dependence after a stroke. the mRS is a scale that runs from 0 (no symptoms) to 6 (death).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acute Stroke</condition>
  <arm_group>
    <arm_group_label>Mobilized Neurointervention Team</arm_group_label>
    <description>Patients undergoing endovascular stroke interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mobilized Patient</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Core Comprehensive Stroke Center Treatment</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acute Endovascular Stroke Treatment</intervention_name>
    <arm_group_label>Mobilized Neurointervention Team</arm_group_label>
    <arm_group_label>Mobilized Patient</arm_group_label>
    <arm_group_label>Core Comprehensive Stroke Center Treatment</arm_group_label>
    <other_name>Solitaire</other_name>
    <other_name>Trevo</other_name>
    <other_name>Embotrap</other_name>
    <other_name>Medtronic</other_name>
    <other_name>Stryker</other_name>
    <other_name>Neuravi</other_name>
    <other_name>Penumbra</other_name>
    <other_name>Microvention</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Clot; Saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who consent to the study and present with acute stroke treated with thrombectomy
        in the Mount Sinai Health System.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - all patients who consent to the study and present with acute stroke treated with
        thrombectomy in the Mount Sinai Health System (Mount Sinai, Mount Sinai West, Mount Sinai
        Beth Israel, Mount Sinai St. Luke's) from 1 June 2016 - 31 December 2018.

        Exclusion criteria:

          -  If the patient is pregnant

          -  Under age 18

          -  A prisoner. If timing of treatment cannot be captured, patients with these data points
             will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johanna Fifi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai West</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai St Luke's</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Health System</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama Ã  Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 Jan 1;372(1):11-20. doi: 10.1056/NEJMoa1411587. Epub 2014 Dec 17. Erratum in: N Engl J Med. 2015 Jan 22;372(4):394.</citation>
    <PMID>25517348</PMID>
  </reference>
  <reference>
    <citation>Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015 Mar 12;372(11):1019-30. doi: 10.1056/NEJMoa1414905. Epub 2015 Feb 11.</citation>
    <PMID>25671798</PMID>
  </reference>
  <reference>
    <citation>Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015 Mar 12;372(11):1009-18. doi: 10.1056/NEJMoa1414792. Epub 2015 Feb 11.</citation>
    <PMID>25671797</PMID>
  </reference>
  <reference>
    <citation>Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du Mesnil de Rochemont R, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015 Jun 11;372(24):2285-95. doi: 10.1056/NEJMoa1415061. Epub 2015 Apr 17.</citation>
    <PMID>25882376</PMID>
  </reference>
  <reference>
    <citation>Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San RomÃ¡n L, Serena J, Abilleira S, RibÃ³ M, MillÃ¡n M, Urra X, Cardona P, LÃ³pez-Cancio E, Tomasello A, CastaÃ±o C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-PÃ©rez M, Goyal M, Demchuk AM, von Kummer R, GallofrÃ© M, DÃ¡valos A; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015 Jun 11;372(24):2296-306. doi: 10.1056/NEJMoa1503780. Epub 2015 Apr 17.</citation>
    <PMID>25882510</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2017</study_first_submitted>
  <study_first_submitted_qc>February 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Embolectomy</keyword>
  <keyword>Embolus</keyword>
  <keyword>Thrombectomy</keyword>
  <keyword>Thrombolysis</keyword>
  <keyword>Thrombus</keyword>
  <keyword>Mobile</keyword>
  <keyword>Interventional</keyword>
  <keyword>Neurointervention</keyword>
  <keyword>Stroke</keyword>
  <keyword>Ischemic</keyword>
  <keyword>Acute</keyword>
  <keyword>Endovascular</keyword>
  <keyword>Cerebrovascular</keyword>
  <keyword>Clot</keyword>
  <keyword>Stent Retriever</keyword>
  <keyword>Tissue Plasminogen Activator</keyword>
  <keyword>Drip and Ship</keyword>
  <keyword>Mothership</keyword>
  <keyword>Trip and Treat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

